Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jenkins, D. J.
Right arrow Articles by Alberti, K. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jenkins, D. J.
Right arrow Articles by Alberti, K. G.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 30, Issue 11 951-954, Copyright © 1981 by American Diabetes Association

ARTICLES

Scope and specificity of acarbose in slowing carbohydrate absorption in man

DJ Jenkins, RH Taylor, DV Goff, H Fielden, JJ Misiewicz, DL Sarson, SR Bloom and KG Alberti

Fifty-gram carbohydrate tolerance tests were performed on healthy volunteers to test the activity and specificity of an alpha-glucoside hydrolase inhibitor, acarbose (BAY g 5421). Two hundred milligrams acarbose reduced the area under the blood glucose response curve by 89% (P less than 0.001) after sucrose by 80% (P less than 0.002) after starch, by 19% (N.S.) after maltose, with no effect on glucose. Breath hydrogen measurements indicated an almost complete malabsorption of the sucrose. At 50 mg acarbose, some reduction in blood glucose and insulin response to sucrose was still seen, but no significant hydrogen production. It is suggested that at lower doses, acarbose may prolong the time course over which carbohydrate is absorbed as does dietary fiber; as with fiber, it may be a useful adjunct to diabetic therapy.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
M. D. Robertson, A. S. T. Bickerton, A. L. Dennis, H. Vidal, D. P. Jewell, and K. N. Frayn
Enhanced Metabolic Cycling in Subjects after Colonic Resection for Ulcerative Colitis
J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2747 - 2754.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Numao, I. Damager, C. Li, T. M. Wrodnigg, A. Begum, C. M. Overall, G. D. Brayer, and S. G. Withers
In Situ Extension as an Approach for Identifying Novel {alpha}-Amylase Inhibitors
J. Biol. Chem., November 12, 2004; 279(46): 48282 - 48291.
[Abstract] [Full Text] [PDF]

Home page
 The Diabetes EducatorHome page
P. R. Bingham and M. C. Riddle
Combined Insulin-Sulfonylurea Treatment of Type II Diabetes
The Diabetes Educator, January 1, 1989; 15(5): 450 - 455.
[PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1981 by the American Diabetes Association.